Biotek-snakken — Februar 2020
-
Vedr. Vadsholts lånte aktier - der mangler,som jeg ser det, to bogstaver i den pressemeddelelse. UD. Han går sammen med Novofonden og udlåner de aktier til emisionen. Når så den forretning er udført, udskriver firmaet nye aktier og tilbageleverer. Zinkler skrev: Han shorter - det er vel ikke helt forkert. Med den kursstigning, der er sket, tjener han jo som en shorter ville have gjort.
-
Interessant emne, der måske beretter til en selvstændig debat. https://www.genengnews.com/a-lists/top-10-companies-leveraging-gene-editing/
-
Zealand Pharma announces bid to acquire Valeritas
Company announcement – No. 01 / 2020 Zealand Pharma announces bid to acquire Valeritas Zealand Pharma (NASDAQ: ZEAL) has submitted a bid to acquire...
GlobeNewswire News Room (www.globenewswire.com)
-
Skal Novo være bange ? https://finance.yahoo.com/news/vtv-therapeutics-announces-positive-results-120010210.html
-
Super positivt, Celgene er ny storaktionær i SUTRO med 7,5% https://ir.sutrobio.com/static-files/30e5666c-4c92-4034-b123-c7b7bbb8747a Kan ikke se de tidligere har stået på listen over storaktionære. Men de havde en aktiepost gennem deres 2014 aftale som bl.a. er en strategisk samarbejdsaftale og giver Celgene ret til at købe hele Sutro så vidt jeg kan forstå. Er der nogle her som har været gennem deres sec filings og har en mening om Celgene partnerskabet ?
-
-
Orphazyme - Hold også øje med aftenens + morgendagens præsentationer ved WorldSymposium https://www.orphazyme.com/news-feed/2020/2/11/orphazyme-announces-presentations-at-worldsymposium
-
Ny storinvestor i Orphazyme. ( MedWatch ). https://medwatch.dk/Medicinal___Biotek/article11937038.ece
-
Vi har været under massivt attack. Beklager nedetiden.
-
-
Coronavirus: Gilead’s Remdesivir Begins Trials as Researchers Publish Positive In Vitro Results
Clinical trials of Gilead Sciences’ remdesivir have begun in Wuhan, China, the center of the novel coronavirus outbreak, a day after Chinese researchers recommended that the antiviral drug candidate remdesivir be assessed in humans as a potential treatment for 2019-nCoV.
GEN - Genetic Engineering and Biotechnology News (www.genengnews.com)
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind